IP Verse

Method Of Treating Cancer Using Selective Estrogen Receptor Modulators - EP3122426

PATENT ANALYSIS

Patent Details

Grant Date
Jan 18, 2023
Company
DUKE UNIVERSITY
Oppositions

SANDOZ AG

TEVA PHARMACEUTICAL INDUSTRIES LTD

More patents of Duke University

EP3122426

EP3360979

Want to monitor this patent?

Feel free to send us a message here and we will get back to you